Respironics buys back outstanding shares:
This article was originally published in Clinica
Executive Summary
Respironics (US) has bought up nearly 5% of the outstanding shares of its common stock. The repurchased stock will be added to the company's treasury shares and may be used to meet common stock requirements of employee benefit plans, stock option plans and other corporate purposes.